These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis. Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966 [TBL] [Abstract][Full Text] [Related]
6. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody. Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative. Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088 [TBL] [Abstract][Full Text] [Related]
9. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588 [TBL] [Abstract][Full Text] [Related]
11. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393 [TBL] [Abstract][Full Text] [Related]
12. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272 [TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745 [TBL] [Abstract][Full Text] [Related]
14. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo. Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272 [TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats. Wu SH; Wu XH; Liao PY; Dong L Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090 [TBL] [Abstract][Full Text] [Related]